Form D · Other
228 Labs, Inc.
Lafayette, CO · CIK 0002077774
Offering snapshot reported Jul 28, 2025 · SEC filing
- Reported sold
- $8.83M Offering amount: $8.83M
- Investors reported
- 31 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 1, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 28, 2025 | Initial | $8,827,490 | No comparison | 31 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-552912
Total Offering Amount includes conversion of outstanding Simple Agreements for Future Equity.
Source: Form D, filed Jul 28, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ian Cairns | Director, Executive, Promoter |
| Eric Ryan | Director, Executive, Promoter |
| Roseanne Wincek | Director |
Issuer details
Industry: Other (See others in industry)
Address:
2770 Arapahoe Road Suite 132 To 723
Lafayette, CO, 80026
Lafayette, CO, 80026